Pattern Recognition by Pentraxins
- 1 January 2009
- book chapter
- Published by Springer Nature
- Vol. 653, 98-116
- https://doi.org/10.1007/978-1-4419-0901-5_7
Abstract
Pentraxins are a family of evolutionarily conserved pattern-recognition proteins that are made up of five identical subunits. Based on the primary structure of the subunit, the pentraxins are divided into two groups: short pentraxins and long pentraxins. C-reactive protein (CRP) and serum amyloid P-component (SAP) are the two short pentraxins. The prototype protein of the long pentraxin group is pentraxin 3 (PTX3). CRP and SAP are produced primarily in the liver while PTX3 is produced in a variety of tissues during inflammation. The main functions of short pentraxins are to recognize a variety of pathogenic agents and then to either eliminate them or neutralize their harmful effects by utilizing the complement pathways and macrophages in the host. CRP binds to modified low-density lipoproteins, bacterial polysaccharides, apoptotic cells, and nuclear materials. By virtue of these recognition functions, CRP participates in the resolution of cardiovascular, infectious, and autoimmune diseases. SAP recognizes carbohydrates, nuclear substances, and amyloid fibrils and thus participates in the resolution of infectious diseases, autoimmunity, and amyloidosis. PTX3 interacts with several ligands, including growth factors, extracellular matrix component and selected pathogens, playing a role in complement activation and facilitating pathogen recognition by phagocytes. In addition, data in gene-targeted mice show that PTX3 is essential in female fertility, participating in the assembly of the cumulus oophorus extracellular matrix. PTX3 is therefore a nonredundant component of the humoral arm of innate immunity as well as a tuner of inflammation. Thus, in conjunction with the other components of innate immunity, the pentraxins use their pattern-recognition property for the benefit of the host.This publication has 215 references indexed in Scilit:
- Analysis of Binding Sites in Human C-reactive Protein for FcγRI, FcγRIIA, and C1q by Site-directed MutagenesisJournal of Biological Chemistry, 2005
- Mice Lacking Serum Amyloid P Component Do Not Necessarily Develop Severe Autoimmune DiseaseBiochemical and Biophysical Research Communications, 2001
- Interactions between rat C-reactive protein and adult Hymenolepis diminutaParasitology, 1997
- Serum amyloid P component-induced cell death in primary cultures of rat cerebral cortexEuropean Journal of Pharmacology: Environmental Toxicology and Pharmacology, 1994
- Therapeutic effects of a synthetic peptide of C-reactive protein in pre-clinical tumor modelsCancer Immunology, Immunotherapy, 1993
- Structure and significance of N-linked sugar unit of human serum amyloid P componentBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1990
- Elucidation of a protease-sensitive site involved in the binding of calcium to C-reactive proteinBiochemistry, 1989
- Effects of C-reactive protein on human neutrophil granulocytes challenged with N-formyl-methionyl-leucyl-phenylalanine and platelet-activating factorLife Sciences, 1989
- Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serumBiochemical and Biophysical Research Communications, 1987
- Inhibition of platelet-activating factor by rabbit C-reactive proteinClinical Immunology and Immunopathology, 1985